Are you a financial expert?Login
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Signup

SHILPAMED

559.5
+0.8 (0.14%)
Updated 03:29 23/09 IST

SHILPAMED Buy or Sell - FrontPage Forums

2 Users have submitted 2 trade ideas of Rs. 214,113 for SHILPAMED
Disclaimer
100% Bullish
0% Bearish

SHILPAMED Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See SHILPAMED Share Price Targets >>

SHILPAMED Ratings

Long term SHILPAMED rating by FrontPage users
  • ★
    ★
  • ★
    ★
  • ★
    ★
  • ★
    ★
  • ★
    ★
0/5 (0 Ratings)0
Find answers to all your questions on live SHILPAMED message board: Is SHILPAMED buy or sell? Should I buy SHILPAMED shares? Why are SHILPAMED shares falling? Should I invest in SHILPAMED stock?

  1. Home
  2. SHILPAMED Forum

SHILPAMED Share Price Discussion

P
PRIT PATEL  @pritpatel
Reputation: 11,481 • Sep 18 8:49 AM
Shilpa Medicare is currently trading at Rs. 593.80, up by 11.15 points or 1.91% from its previous closing of Rs. 582.65 on the BSE.

The scrip opened at Rs. 586.00 and has touched a high and low of Rs. 615.60 and Rs. 581.00 respectively. So far 104582 shares were traded on the co...
Read more...
Like
Reply
S
Shyam @shyam-rkB22simD
Reputation: -20,639 • Sep 18 8:49 AM
Type
Buy
Instrument
SIEMENS SEP20 1260 CE
Entry Price
₹22.5
Price@Trade
₹23
Target Price
₹30
Stop Price
₹19
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹24,750 approx for 1100 Qty
Status
Waiting for entry
#SIEMENS
Like
Reply
S
Small Income Trader @Smallincom
Reputation: 49,945 • Sep 18 8:49 AM
Type
Buy
Instrument
BANKNIFTY 24SEP20 22100 CE
Entry Price
₹350
Price@Trade
₹359.8
Target Price
₹400
Stop Price
₹340
Valid Till
Sep 21, 2020 3:20 AM
Margin
₹875,000 approx for 2500 Qty
Status
Waiting for entry
#NIFTYBANK
Like
Reply
A
Avhi singh @avhi
Reputation: 858 • Sep 18 8:49 AM
Type
Buy
Instrument
BANKNIFTY 24SEP20 22400 CE
Entry Price
₹226
Price@Trade
₹228.25
Target Price
₹232
Stop Price
₹220
Valid Till
Sep 21, 2020 3:20 AM
Margin
₹452,000 approx for 2000 Qty
Status
Waiting for entry
#NIFTYBANK
Like
Reply
J
JC Singh @jcsingh
Reputation: -1,333 • Sep 18 8:49 AM
Type
Buy
Instrument
BANKNIFTY 24SEP20 21800 PE
Entry Price
₹240
Price@Trade
₹240
Target Price
₹280
Stop Price
₹220
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹6,000 approx for 25 Qty
Status
Active
#NIFTYBANK
Like
Reply
S
StockEarnings @vatsal1227
Reputation: 4,669 • Sep 18 8:48 AM
StockEarnings in BHARTIARTL
New trade: Buy BHARTIARTL OCT20 FUT, CMP@479.55...
497++. rocking. hold for target#StockEarnings
#BHARTIARTL
Like
Reply
J
Jbn @jbn
Reputation: 368,265 • Sep 18 8:47 AM
Type
Buy
Instrument
SHREECEM OCT20 FUT
Entry Price
₹19,611.65
Price@Trade
₹19,611.65
Target Price
₹21,400
Stop Price
₹18,000
Valid Till
Oct 29, 2020 3:20 AM
Margin
₹4,563,647.75 approx for 1000 Qty
Status
Active
#SHREECEM
Like
Reply
A
Avhi singh @avhi
Reputation: 858 • Sep 18 8:47 AM
Type
Buy
Instrument
BANKNIFTY 24SEP20 22400 CE
Entry Price
₹230
Price@Trade
₹230.75
Target Price
₹234
Stop Price
₹226
Valid Till
Sep 18, 2020 3:20 AM
Margin
₹230,000 approx for 1000 Qty
Status
Exited before entry
#NIFTYBANK
Like
Reply (1)
See all replies
Avhi singh @avhi
•
Sep 18 8:48 AM
Update
Exited before entry
Price @ Update
₹230.7
R
Rishabh  @rishabh918
Reputation: -4,582 • Sep 18 8:47 AM
Type
Buy
Instrument
NIFTY 24SEP20 11500 CE
Entry Price
₹105  ₹107
Price@Trade
₹104.6
Target Price
₹150
Stop Price
₹100
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹802,500 approx for 7500 Qty
Status
Active
#NIFTY50
Like
Reply (10)
See all replies
Rishabh  @rishabh918
•
Sep 18 8:49 AM
Update
Entry Price Modified
Price @ Update
₹106.45
Original Entry Price
₹108
New Entry Price
₹106
Rishabh  @rishabh918
•
Sep 18 8:49 AM
Update
Entry Price Modified
Price @ Update
₹106.7
Original Entry Price
₹106
New Entry Price
₹107
TrackerBot @trackerbot
•
Sep 18 8:49 AM
Update
Trade Entered
Entry Price
₹107
S
Sameer @smsameeruddin
Reputation: 104,289 • Sep 18 8:47 AM
Sameer in NIFTY-50
New trade: Buy NIFTY 24SEP20 11550 PE, CMP@106,...
Like
Reply
A
Ankit Mishra @ankit11
Reputation: -12,127 • Sep 18 8:47 AM
Type
Buy
Instrument
ICICIBANK OCT20 400 CE
Entry Price
₹11.4
Price@Trade
₹11.6
Target Price
₹25
Stop Price
₹9
Valid Till
Oct 29, 2020 3:20 AM
Margin
₹78,375 approx for 6875 Qty
Status
Active
#ICICIBANK
Like
Reply (1)
See all replies
TrackerBot @trackerbot
•
Sep 18 8:49 AM
Update
Trade Entered
Entry Price
₹11.4
S
Sheik @sheik-SJMq-ZRNw
Reputation: 559 • Sep 18 8:46 AM
Type
Buy
Instrument
BAJAJHLDNG
Entry Price
₹2,605.7
Price@Trade
₹2,605.7
Target Price
₹5,000
Stop Price
₹2,530
Valid Till
Sep 17, 2021 3:20 AM
Margin
₹26,057 approx for 10 Qty
Status
Active
#BAJAJHLDNG
Like
Reply
S
StockEarnings @vatsal1227
Reputation: 4,669 • Sep 18 8:46 AM
StockEarnings in LICHSGFIN
13.8++ 50% gain now... book half. hold rest.#St...
Like
Reply
R
Raj @raj-B1HcCXO58
Reputation: -30,374 • Sep 18 8:46 AM
Type
Buy
Instrument
BANKNIFTY 24SEP20 22200 PE
Entry Price
₹350
Price@Trade
₹430.7
Target Price
₹400
Stop Price
₹300
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹70,000 approx for 200 Qty
Status
Waiting for entry
#NIFTYBANK
Like
Reply
C
Crude Analyst @crudeanalyst
Reputation: 587 • Sep 18 8:46 AM
Type
Sell
Instrument
CRUDEOIL 21SEP20 FUT
Entry Price
₹3,019
Price@Trade
₹3,019
Target Price
₹2,996
Stop Price
₹3,039
Valid Till
Sep 18, 2020 11:20 AM
Margin
₹306,173.75 approx for 100 Qty
Status
Active
#CRUDEOIL
Like
Reply
R
Raja @raja-BJYkoMFQL
Reputation: 26,159 • Sep 18 8:46 AM
Type
Buy
Instrument
PVR SEP20 1220 CE
Entry Price
₹34.9
Price@Trade
₹34.9
Target Price
₹55
Stop Price
₹18
Valid Till
Sep 21, 2020 3:20 AM
Margin
₹139,600 approx for 4000 Qty
Status
Active
#PVR
Like
Reply
S
SAMRAT BANIK @samratbanik
Reputation: 203 • Sep 18 8:46 AM
Type
Sell
Instrument
NIFTY 24SEP20 11300 PE
Entry Price
₹38  ₹38.55
Price@Trade
₹37.5
Target Price
₹14
Stop Price
₹50
Valid Till
Sep 18, 2020 3:20 AM
Margin
₹478,409.17 approx for 225 Qty
Status
Exited
Exit Price
₹35.65
Net P&L
+₹652.5 (+0.14%)
#NIFTY50
Like
Reply (3)
See all replies
SAMRAT BANIK @samratbanik
•
Sep 18 8:46 AM
Update
Entry Price Modified
Price @ Update
₹38.55
Original Entry Price
₹38
New Entry Price
₹38.55
TrackerBot @trackerbot
•
Sep 18 8:47 AM
Update
Trade Entered
Entry Price
₹38.55
SAMRAT BANIK @samratbanik
•
Sep 18 8:48 AM
Update
Exited
Exit Price
₹35.65
Net P&L
+₹652.5 (+0.14%)
A
Anand Maheswari @anandmaheswari
Reputation: -4,291 • Sep 18 8:46 AM
Type
Sell
Instrument
TATASTEEL SEP20 FUT
Entry Price
₹395.2  ₹394.85
Price@Trade
₹395.4
Target Price
₹370
Stop Price
₹410
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹214,996.88 approx for 1700 Qty
Status
Active
#TATASTEEL
Like
Reply (3)
See all replies
Anand Maheswari @anandmaheswari
•
Sep 18 8:46 AM
Update
Entry Price Modified
Price @ Update
₹394.7
Original Entry Price
₹395.2
New Entry Price
₹394.7
Anand Maheswari @anandmaheswari
•
Sep 18 8:46 AM
Update
Entry Price Modified
Price @ Update
₹394.85
Original Entry Price
₹394.7
New Entry Price
₹394.85
TrackerBot @trackerbot
•
Sep 18 8:47 AM
Update
Trade Entered
Entry Price
₹394.85
T
TradeFox by parnan @vasuamitparikh
Reputation: -5,160 • Sep 18 8:46 AM
Type
Buy
Instrument
BANKNIFTY 24SEP20 22200 PE
Entry Price
₹435  ₹431.55
Price@Trade
₹430.55
Target Price
₹900
Stop Price
₹200
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹107,887.5 approx for 250 Qty
Status
Active
#NIFTYBANK
Like
Reply (2)
See all replies
TradeFox by parnan @vasuamitparikh
•
Sep 18 8:46 AM
Update
Entry Price Modified
Price @ Update
₹431.55
Original Entry Price
₹435
New Entry Price
₹431.55
TrackerBot @trackerbot
•
Sep 18 8:47 AM
Update
Trade Entered
Entry Price
₹431.55
R
Rishabh  @rishabh918
Reputation: -4,582 • Sep 18 8:45 AM
Type
Buy
Instrument
NIFTY 24SEP20 11600 PE
Entry Price
₹142.15
Price@Trade
₹142.15
Target Price
₹155
Stop Price
₹135
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹1,066,125 approx for 7500 Qty
Status
Exited
Exit Price
₹141.8
Net P&L
-₹2,625 (-0.25%)
#NIFTY50
Like
Reply (1)
See all replies
Rishabh  @rishabh918
•
Sep 18 8:46 AM
Update
Exited
Exit Price
₹141.8
Net P&L
-₹2,625 (-0.25%)
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
Join FrontPage

  • SHILPAMED - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization2,772.63
    Enterprise Value2,841.7
    Price to Earnings28.49
    Price to Book Value2.16
    Return on Capital Employed0.13
    Return on Equity0.12
    Face Value1
    Dividend YieldNA

  • SHILPAMED - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    8-Feb-19Motilal OswalBuy480
    21-Jan-19Motilal OswalBuy620
    15-Nov-18Motilal OswalBuy575
    14-Aug-18Motilal OswalBuy620
    3-Apr-18Motilal OswalBuy686
    SHILPAMED Brokerage Price Target

  • SHILPAMED Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 23566572545.4560.4
    Sep 21602623.2557.5564.95
    Sep 18585.95615.75580.55596.05
    Sep 17570.5593.95567582.85
    Sep 16565.1585.4554.2577.3

  • SHILPAMED Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹553.11
    30 Day Moving Average₹570.71
    50 Day Moving Average₹561.34
    100 Day Moving Average₹503.63
    200 Day Moving Average₹418.87

  • SHILPAMED - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue741733.420.01
    Operating Profit179182.23-0.02
    Profit Before Tax167170.29-0.02
    Net Income133126.590.05

  • SHILPAMED - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,2811,1570.11
    Total Liabilities387425-0.09
    Total Assets1,6681,5820.05

  • SHILPAMED - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity5438.290.41
    Cash from Investing Activity-13-266.89-0.95
    Cash from Financing Activity-62316.32-1.2
    Net Cash Flow-2087.72-1.23

  • SHILPAMED - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.080.09
    Return on Equity0.120.13
    Return on Capital Employed0.130.15

  • SHILPAMED - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.31
    3 Year CAGR Growth in Operating Profit0.31
    3 Year CAGR Growth in EBIDTA0.42
    3 Year CAGR Growth in Net Income0.58
    3 Yr CAGR Growth - Diluted EPS-0.25

  • SHILPAMED - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.26
    5 Year CAGR Growth in Operating Profit1.74
    5 Year CAGR Growth in EBIDTA1.87
    5 Year CAGR Growth in Net Income1.89
    3 Yr CAGR Growth - Diluted EPS-0.13

  • SHILPAMED - Recent News

    keyboard_arrow_down
    NewsBot
    Jun 30 4:13 AM
    Shilpa Medicare gains 5% on launch of generic drug for kidney cancer
    Moneycontrol
    NewsBot
    Jun 16 9:13 AM
    Shilpa Medicare shares fall 9% despite strong a Q4 result
    Moneycontrol
    NewsBot
    Jun 5 1:58 AM
    Gladiator Stocks - Shilpa Medicare: ICICI Securities
    Moneycontrol
    NewsBot
    May 28 5:43 AM
    Shilpa Medicare share price rises nearly 5% on launching anti-cancer drug
    Moneycontrol
    NewsBot
    Apr 24 3:33 AM
    Shilpa Medicare share price gains nearly 3% on launch of anti-cancer drug
    Moneycontrol
    NewsBot
    Apr 7 8:58 AM
    Shilpa Medicare locked in upper circuit on UK nod for anti-cancer drug
    Moneycontrol
    NewsBot
    Apr 6 11:13 AM
    Shilpa Medicare's subsidiary gets UK regulator nod for anti-cancer drug
    Moneycontrol
    NewsBot
    Feb 26 6:33 AM
    Shilpa Medicare share price locked at lower circuit on 15 observations from USFDA
    Moneycontrol
    NewsBot
    Feb 25 5:43 AM
    Shilpa Medicare locked in upper circuit after board nod for biological unit sale
    Moneycontrol
    NewsBot
    Feb 3 4:03 AM
    Shilpa Medicare share price gains nearly 6% on USFDA nod
    Moneycontrol

  • SHILPAMED - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
Privacy•Terms•••
FrontPage © 2020